PharmswellBio Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PharmswellBio Co Ltd with three other
companies in this sector in South Korea:
Nibec
(2016
sales of 4.80 billion Korean Won [US$4.25 million]
),
Mezzion Pharma Co Ltd
(8.75 billion Korean Won [US$7.74 million]
of which 56%
was New drugs sector), and
AnyGen Co Ltd
(4.18 billion Korean Won [US$3.69 million]
).
Sales Analysis.
During the year ended December of 2016, sales at
PharmswellBio Co Ltd were 15.72 billion Korean Won (US$13.90 million).
This
is
a
decrease of 16.7%
versus 2015, when the company's sales were 18.87 billion Korean Won.